The Global Anticoagulant Reversal Drugs Market size is expected to reach $1.6 billion by 2027, rising at a market growth of 13.3% CAGR during the forecast period. Anticoagulant reversal is a medical procedure for the management of patients suffering from severe bleeding problems who are consuming an anticoagulant. Intake of reversal anticoagulant drug depends on type of anticoagulant a patient is taking. Though, majority of reversal agents can sometimes increase the risk of thromboembolic events. Therefore, these drugs should be used only in severe or life-threatening bleeding cases. Also, there should be thorough & careful monitoring of the Patients is required who are taking anticoagulation reversal drugs to avoid any untoward incident.
Hemophilia A and B, blood clots, and Von Willebrand disease (VWD) are some of the common bleeding disorders. As per the National Hemophilia Foundation (NHF), there are approximately 30,000 to 33,000 people in the U.S. who are suffering from hemophilia and about 60% of them have acute hemophilia. According to the CDC estimations, around 400 babies are born with hemophilia A per year. Von Willebrand disease is a very common bleeding disorder that affects 1 out of 100 individuals. Bleeding disorders affect blood clotting or may also cause undesirable bleeding from the patient’s body. These blood-related disorders require anticoagulants that further boost the demand for anticoagulant reversal drugs in case of uncontrolled bleeding.
COVID-19 Impact:
The sudden outbreak of COVID-19 has a significant impact on the anticoagulant reversal drugs with the growing number of research and development activities mainly on COVID-19 infection. For example, an article published in the American Journal of Cardiovascular Drugs in 2020 revealed that about 10 clinical trials are ongoing in order to evaluate how effective the factor Xa inhibitors are in COVID-19 patients. Research studies are continuing on developing the strategies for the parenteral administration of these drugs that are useful in the treatment of severe COVID-19 patients. Therefore, the COVID-19 pandemic is expected to fuel the growth of the anticoagulant drug market.
Distribution Channel Outlook
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. In 2020, the Retail pharmacy obtained the second-highest revenue share of the market. This segment includes specialty pharmacies and other retail pharmacies. Specialty drugs expected to grow at a considerable pace in the future pharmacy business. Moreover, the growth of the segment is expected to be augmented by the factors like increasing penetration of retail pharmacies in developing economies having inadequate access to hospitals and online pharmacies.
Product Type Outlook
Based on Product Type, the market is segmented into Idarucizumab, Andexanet Alfa, Prothrombin Complex Concentrates, Phytonadione, Protamine and Others. The idarucizumab segment garnered the highest revenue share of the global market in 2020. It is expected to showcase similar trend in the forecast period. This is due to the increasing revenue generation by idarucizumab in leading geographies across the globe.
Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region of the global market in 2020. It is likely to maintain this trend over the forecast period. The U.S. procured the highest share in the North American anticoagulant reversal drug market. The high healthcare expenditure and satisfactory healthcare reimbursement policies with respect to expensive drugs are the key driving factors in the market. In addition to it, the easy accessibility of these reversal drugs in an emergency situation also boosts the regional market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, CSL Limited, Bausch Health Companies, Inc., Octapharma AG, Pfizer, Inc., Fresenius SE & Co. KGaA, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), Dr. Reddy’s Laboratories Ltd., AMAG Pharmaceuticals, Inc. (Covis Pharma), and Alps Pharmaceutical Ind. Co., Ltd.
Scope of the Study
Market Segments covered in the Report:
By Distribution Channel
By Product Type
By Geography
Companies Profiled
Unique Offerings from the Publisher
Hemophilia A and B, blood clots, and Von Willebrand disease (VWD) are some of the common bleeding disorders. As per the National Hemophilia Foundation (NHF), there are approximately 30,000 to 33,000 people in the U.S. who are suffering from hemophilia and about 60% of them have acute hemophilia. According to the CDC estimations, around 400 babies are born with hemophilia A per year. Von Willebrand disease is a very common bleeding disorder that affects 1 out of 100 individuals. Bleeding disorders affect blood clotting or may also cause undesirable bleeding from the patient’s body. These blood-related disorders require anticoagulants that further boost the demand for anticoagulant reversal drugs in case of uncontrolled bleeding.
COVID-19 Impact:
The sudden outbreak of COVID-19 has a significant impact on the anticoagulant reversal drugs with the growing number of research and development activities mainly on COVID-19 infection. For example, an article published in the American Journal of Cardiovascular Drugs in 2020 revealed that about 10 clinical trials are ongoing in order to evaluate how effective the factor Xa inhibitors are in COVID-19 patients. Research studies are continuing on developing the strategies for the parenteral administration of these drugs that are useful in the treatment of severe COVID-19 patients. Therefore, the COVID-19 pandemic is expected to fuel the growth of the anticoagulant drug market.
Distribution Channel Outlook
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. In 2020, the Retail pharmacy obtained the second-highest revenue share of the market. This segment includes specialty pharmacies and other retail pharmacies. Specialty drugs expected to grow at a considerable pace in the future pharmacy business. Moreover, the growth of the segment is expected to be augmented by the factors like increasing penetration of retail pharmacies in developing economies having inadequate access to hospitals and online pharmacies.
Product Type Outlook
Based on Product Type, the market is segmented into Idarucizumab, Andexanet Alfa, Prothrombin Complex Concentrates, Phytonadione, Protamine and Others. The idarucizumab segment garnered the highest revenue share of the global market in 2020. It is expected to showcase similar trend in the forecast period. This is due to the increasing revenue generation by idarucizumab in leading geographies across the globe.
Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region of the global market in 2020. It is likely to maintain this trend over the forecast period. The U.S. procured the highest share in the North American anticoagulant reversal drug market. The high healthcare expenditure and satisfactory healthcare reimbursement policies with respect to expensive drugs are the key driving factors in the market. In addition to it, the easy accessibility of these reversal drugs in an emergency situation also boosts the regional market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, CSL Limited, Bausch Health Companies, Inc., Octapharma AG, Pfizer, Inc., Fresenius SE & Co. KGaA, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), Dr. Reddy’s Laboratories Ltd., AMAG Pharmaceuticals, Inc. (Covis Pharma), and Alps Pharmaceutical Ind. Co., Ltd.
Scope of the Study
Market Segments covered in the Report:
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Product Type
- Idarucizumab
- Andexanet Alfa
- Prothrombin Complex Concentrates
- Phytonadione
- Protamine
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Boehringer Ingelheim International GmbH
- CSL Limited
- Bausch Health Companies, Inc.
- Octapharma AG
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- Dr. Reddy’s Laboratories Ltd.
- AMAG Pharmaceuticals, Inc. (Covis Pharma)
- Alps Pharmaceutical Ind. Co., Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Anticoagulant Reversal Drugs Market, by Distribution Channel
1.4.2 Global Anticoagulant Reversal Drugs Market, by Product Type
1.4.3 Global Anticoagulant Reversal Drugs Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Opportunities:
Chapter 3. Global Anticoagulant Reversal Drugs Market by Distribution Channel
3.1 Global Hospital Pharmacy Market by Region
3.2 Global Retail Pharmacy Market by Region
3.3 Global Online Pharmacy Market by Region
Chapter 4. Global Anticoagulant Reversal Drugs Market by Product Type
4.1 Global Idarucizumab Market by Region
4.2 Global Andexanet Alfa Market by Region
4.3 Global Prothrombin Complex Concentrates Market by Region
4.4 Global Phytonadione Market by Region
4.5 Global Protamine Market by Region
4.6 Global Other Product Type Market by Region
Chapter 5. Global Anticoagulant Reversal Drugs Market by Region
5.1 North America Anticoagulant Reversal Drugs Market
5.1.1 North America Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.1.1 North America Hospital Pharmacy Market by Country
5.1.1.2 North America Retail Pharmacy Market by Country
5.1.1.3 North America Online Pharmacy Market by Country
5.1.2 North America Anticoagulant Reversal Drugs Market by Product Type
5.1.2.1 North America Idarucizumab Market by Country
5.1.2.2 North America Andexanet Alfa Market by Country
5.1.2.3 North America Prothrombin Complex Concentrates Market by Country
5.1.2.4 North America Phytonadione Market by Country
5.1.2.5 North America Other Product Type Market by Country
5.1.3 North America Anticoagulant Reversal Drugs Market by Country
5.1.3.1 US Anticoagulant Reversal Drugs Market
5.1.3.1.1 US Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.3.1.2 US Anticoagulant Reversal Drugs Market by Product Type
5.1.3.2 Canada Anticoagulant Reversal Drugs Market
5.1.3.2.1 Canada Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.3.2.2 Canada Anticoagulant Reversal Drugs Market by Product Type
5.1.3.3 Mexico Anticoagulant Reversal Drugs Market
5.1.3.3.1 Mexico Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.3.3.2 Mexico Anticoagulant Reversal Drugs Market by Product Type
5.1.3.4 Rest of North America Anticoagulant Reversal Drugs Market
5.1.3.4.1 Rest of North America Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.3.4.2 Rest of North America Anticoagulant Reversal Drugs Market by Product Type
5.2 Europe Anticoagulant Reversal Drugs Market
5.2.1 Europe Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.1.1 Europe Hospital Pharmacy Market by Country
5.2.1.2 Europe Retail Pharmacy Market by Country
5.2.1.3 Europe Online Pharmacy Market by Country
5.2.2 Europe Anticoagulant Reversal Drugs Market by Product Type
5.2.2.1 Europe Idarucizumab Market by Country
5.2.2.2 Europe Andexanet Alfa Market by Country
5.2.2.3 Europe Prothrombin Complex Concentrates Market by Country
5.2.2.4 Europe Phytonadione Market by Country
5.2.2.5 Europe Other Product Type Market by Country
5.2.3 Europe Anticoagulant Reversal Drugs Market by Country
5.2.3.1 Germany Anticoagulant Reversal Drugs Market
5.2.3.1.1 Germany Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.3.1.2 Germany Anticoagulant Reversal Drugs Market by Product Type
5.2.3.2 UK Anticoagulant Reversal Drugs Market
5.2.3.2.1 UK Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.3.2.2 UK Anticoagulant Reversal Drugs Market by Product Type
5.2.3.3 France Anticoagulant Reversal Drugs Market
5.2.3.3.1 France Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.3.3.2 France Anticoagulant Reversal Drugs Market by Product Type
5.2.3.4 Russia Anticoagulant Reversal Drugs Market
5.2.3.4.1 Russia Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.3.4.2 Russia Anticoagulant Reversal Drugs Market by Product Type
5.2.3.5 Spain Anticoagulant Reversal Drugs Market
5.2.3.5.1 Spain Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.3.5.2 Spain Anticoagulant Reversal Drugs Market by Product Type
5.2.3.6 Italy Anticoagulant Reversal Drugs Market
5.2.3.6.1 Italy Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.3.6.2 Italy Anticoagulant Reversal Drugs Market by Product Type
5.2.3.7 Rest of Europe Anticoagulant Reversal Drugs Market
5.2.3.7.1 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.3.7.2 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type
5.3 Asia Pacific Anticoagulant Reversal Drugs Market
5.3.1 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.1.1 Asia Pacific Hospital Pharmacy Market by Country
5.3.1.2 Asia Pacific Retail Pharmacy Market by Country
5.3.1.3 Asia Pacific Online Pharmacy Market by Country
5.3.2 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type
5.3.2.1 Asia Pacific Idarucizumab Market by Country
5.3.2.2 Asia Pacific Andexanet Alfa Market by Country
5.3.2.3 Asia Pacific Prothrombin Complex Concentrates Market by Country
5.3.2.4 Asia Pacific Phytonadione Market by Country
5.3.2.5 Asia Pacific Other Product Type Market by Country
5.3.3 Asia Pacific Anticoagulant Reversal Drugs Market by Country
5.3.3.1 China Anticoagulant Reversal Drugs Market
5.3.3.1.1 China Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.3.1.2 China Anticoagulant Reversal Drugs Market by Product Type
5.3.3.2 Japan Anticoagulant Reversal Drugs Market
5.3.3.2.1 Japan Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.3.2.2 Japan Anticoagulant Reversal Drugs Market by Product Type
5.3.3.3 India Anticoagulant Reversal Drugs Market
5.3.3.3.1 India Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.3.3.2 India Anticoagulant Reversal Drugs Market by Product Type
5.3.3.4 South Korea Anticoagulant Reversal Drugs Market
5.3.3.4.1 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.3.4.2 South Korea Anticoagulant Reversal Drugs Market by Product Type
5.3.3.5 Singapore Anticoagulant Reversal Drugs Market
5.3.3.5.1 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.3.5.2 Singapore Anticoagulant Reversal Drugs Market by Product Type
5.3.3.6 Malaysia Anticoagulant Reversal Drugs Market
5.3.3.6.1 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.3.6.2 Malaysia Anticoagulant Reversal Drugs Market by Product Type
5.3.3.7 Rest of Asia Pacific Anticoagulant Reversal Drugs Market
5.3.3.7.1 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.3.7.2 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type
5.4 LAMEA Anticoagulant Reversal Drugs Market
5.4.1 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.1.1 LAMEA Hospital Pharmacy Market by Country
5.4.1.2 LAMEA Retail Pharmacy Market by Country
5.4.1.3 LAMEA Online Pharmacy Market by Country
5.4.2 LAMEA Anticoagulant Reversal Drugs Market by Product Type
5.4.2.1 LAMEA Idarucizumab Market by Country
5.4.2.2 LAMEA Andexanet Alfa Market by Country
5.4.2.3 LAMEA Prothrombin Complex Concentrates Market by Country
5.4.2.4 LAMEA Phytonadione Market by Country
5.4.2.5 LAMEA Other Product Type Market by Country
5.4.3 LAMEA Anticoagulant Reversal Drugs Market by Country
5.4.3.1 Brazil Anticoagulant Reversal Drugs Market
5.4.3.1.1 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.3.1.2 Brazil Anticoagulant Reversal Drugs Market by Product Type
5.4.3.2 Argentina Anticoagulant Reversal Drugs Market
5.4.3.2.1 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.3.2.2 Argentina Anticoagulant Reversal Drugs Market by Product Type
5.4.3.3 UAE Anticoagulant Reversal Drugs Market
5.4.3.3.1 UAE Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.3.3.2 UAE Anticoagulant Reversal Drugs Market by Product Type
5.4.3.4 Saudi Arabia Anticoagulant Reversal Drugs Market
5.4.3.4.1 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.3.4.2 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type
5.4.3.5 South Africa Anticoagulant Reversal Drugs Market
5.4.3.5.1 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.3.5.2 South Africa Anticoagulant Reversal Drugs Market by Product Type
5.4.3.6 Nigeria Anticoagulant Reversal Drugs Market
5.4.3.6.1 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.3.6.2 Nigeria Anticoagulant Reversal Drugs Market by Product Type
5.4.3.7 Rest of LAMEA Anticoagulant Reversal Drugs Market
5.4.3.7.1 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.3.7.2 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type
Chapter 6. Company Profiles
6.1 Boehringer Ingelheim International GmbH
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Octapharma AG
6.4.1 Company Overview
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Fresenius SE & Co. KGaA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Approvals:
6.8 Dr. Reddy’s Laboratories Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 AMAG Pharmaceuticals, Inc. (Covis Pharma)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Research & Development Expenses
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.9.4.2 Acquisition and Mergers:
6.10. Alps Pharmaceutical Ind. Co., Ltd.
6.10.1 Company OverviewList of Tables
Table 1 Global Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 2 Global Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 3 Global Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 4 Global Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 5 Global Hospital Pharmacy Market by Region, 2017 - 2020, USD Million
Table 6 Global Hospital Pharmacy Market by Region, 2021-2027, USD Million
Table 7 Global Retail Pharmacy Market by Region, 2017 - 2020, USD Million
Table 8 Global Retail Pharmacy Market by Region, 2021-2027, USD Million
Table 9 Global Online Pharmacy Market by Region, 2017 - 2020, USD Million
Table 10 Global Online Pharmacy Market by Region, 2021-2027, USD Million
Table 11 Global Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 12 Global Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 13 Global Idarucizumab Market by Region, 2017 - 2020, USD Million
Table 14 Global Idarucizumab Market by Region, 2021-2027, USD Million
Table 15 Global Andexanet Alfa Market by Region, 2017 - 2020, USD Million
Table 16 Global Andexanet Alfa Market by Region, 2021-2027, USD Million
Table 17 Global Prothrombin Complex Concentrates Market by Region, 2017 - 2020, USD Million
Table 18 Global Prothrombin Complex Concentrates Market by Region, 2021-2027, USD Million
Table 19 Global Phytonadione Market by Region, 2017 - 2020, USD Million
Table 20 Global Phytonadione Market by Region, 2021-2027, USD Million
Table 21 Global Protamine Market by Region, 2017 - 2020, USD Million
Table 22 Global Protamine Market by Region, 2021-2027, USD Million
Table 23 Global Other Product Type Market by Region, 2017 - 2020, USD Million
Table 24 Global Other Product Type Market by Region, 2021-2027, USD Million
Table 25 Global Anticoagulant Reversal Drugs Market by Region, 2017 - 2020, USD Million
Table 26 Global Anticoagulant Reversal Drugs Market by Region, 2021-2027, USD Million
Table 27 North America Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 28 North America Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 29 North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 30 North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 31 North America Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
Table 32 North America Hospital Pharmacy Market by Country, 2021-2027, USD Million
Table 33 North America Retail Pharmacy Market by Country, 2017 - 2020, USD Million
Table 34 North America Retail Pharmacy Market by Country, 2021-2027, USD Million
Table 35 North America Online Pharmacy Market by Country, 2017 - 2020, USD Million
Table 36 North America Online Pharmacy Market by Country, 2021-2027, USD Million
Table 37 North America Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 38 North America Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 39 North America Idarucizumab Market by Country, 2017 - 2020, USD Million
Table 40 North America Idarucizumab Market by Country, 2021-2027, USD Million
Table 41 North America Andexanet Alfa Market by Country, 2017 - 2020, USD Million
Table 42 North America Andexanet Alfa Market by Country, 2021-2027, USD Million
Table 43 North America Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
Table 44 North America Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
Table 45 North America Phytonadione Market by Country, 2017 - 2020, USD Million
Table 46 North America Phytonadione Market by Country, 2021-2027, USD Million
Table 47 North America Other Product Type Market by Country, 2017 - 2020, USD Million
Table 48 North America Other Product Type Market by Country, 2021-2027, USD Million
Table 49 North America Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
Table 50 North America Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
Table 51 US Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 52 US Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 53 US Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 54 US Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 55 US Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 56 US Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 57 Canada Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 58 Canada Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 59 Canada Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 60 Canada Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 61 Canada Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 62 Canada Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 63 Mexico Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 64 Mexico Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 65 Mexico Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 66 Mexico Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 67 Mexico Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 68 Mexico Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 69 Rest of North America Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 70 Rest of North America Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 71 Rest of North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 72 Rest of North America Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 73 Rest of North America Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 74 Rest of North America Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 75 Europe Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 76 Europe Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 77 Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 78 Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 79 Europe Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
Table 80 Europe Hospital Pharmacy Market by Country, 2021-2027, USD Million
Table 81 Europe Retail Pharmacy Market by Country, 2017 - 2020, USD Million
Table 82 Europe Retail Pharmacy Market by Country, 2021-2027, USD Million
Table 83 Europe Online Pharmacy Market by Country, 2017 - 2020, USD Million
Table 84 Europe Online Pharmacy Market by Country, 2021-2027, USD Million
Table 85 Europe Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 86 Europe Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 87 Europe Idarucizumab Market by Country, 2017 - 2020, USD Million
Table 88 Europe Idarucizumab Market by Country, 2021-2027, USD Million
Table 89 Europe Andexanet Alfa Market by Country, 2017 - 2020, USD Million
Table 90 Europe Andexanet Alfa Market by Country, 2021-2027, USD Million
Table 91 Europe Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
Table 92 Europe Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
Table 93 Europe Phytonadione Market by Country, 2017 - 2020, USD Million
Table 94 Europe Phytonadione Market by Country, 2021-2027, USD Million
Table 95 Europe Other Product Type Market by Country, 2017 - 2020, USD Million
Table 96 Europe Other Product Type Market by Country, 2021-2027, USD Million
Table 97 Europe Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
Table 98 Europe Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
Table 99 Germany Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 100 Germany Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 101 Germany Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 102 Germany Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 103 Germany Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 104 Germany Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 105 UK Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 106 UK Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 107 UK Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 108 UK Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 109 UK Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 110 UK Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 111 France Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 112 France Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 113 France Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 114 France Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 115 France Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 116 France Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 117 Russia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 118 Russia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 119 Russia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 120 Russia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 121 Russia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 122 Russia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 123 Spain Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 124 Spain Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 125 Spain Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 126 Spain Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 127 Spain Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 128 Spain Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 129 Italy Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 130 Italy Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 131 Italy Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 132 Italy Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 133 Italy Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 134 Italy Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 135 Rest of Europe Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 136 Rest of Europe Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 137 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 138 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 139 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 140 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 141 Asia Pacific Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 142 Asia Pacific Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 143 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 144 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 145 Asia Pacific Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
Table 146 Asia Pacific Hospital Pharmacy Market by Country, 2021-2027, USD Million
Table 147 Asia Pacific Retail Pharmacy Market by Country, 2017 - 2020, USD Million
Table 148 Asia Pacific Retail Pharmacy Market by Country, 2021-2027, USD Million
Table 149 Asia Pacific Online Pharmacy Market by Country, 2017 - 2020, USD Million
Table 150 Asia Pacific Online Pharmacy Market by Country, 2021-2027, USD Million
Table 151 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 152 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 153 Asia Pacific Idarucizumab Market by Country, 2017 - 2020, USD Million
Table 154 Asia Pacific Idarucizumab Market by Country, 2021-2027, USD Million
Table 155 Asia Pacific Andexanet Alfa Market by Country, 2017 - 2020, USD Million
Table 156 Asia Pacific Andexanet Alfa Market by Country, 2021-2027, USD Million
Table 157 Asia Pacific Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
Table 158 Asia Pacific Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
Table 159 Asia Pacific Phytonadione Market by Country, 2017 - 2020, USD Million
Table 160 Asia Pacific Phytonadione Market by Country, 2021-2027, USD Million
Table 161 Asia Pacific Other Product Type Market by Country, 2017 - 2020, USD Million
Table 162 Asia Pacific Other Product Type Market by Country, 2021-2027, USD Million
Table 163 Asia Pacific Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
Table 164 Asia Pacific Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
Table 165 China Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 166 China Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 167 China Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 168 China Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 169 China Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 170 China Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 171 Japan Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 172 Japan Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 173 Japan Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 174 Japan Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 175 Japan Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 176 Japan Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 177 India Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 178 India Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 179 India Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 180 India Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 181 India Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 182 India Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 183 South Korea Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 184 South Korea Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 185 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 186 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 187 South Korea Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 188 South Korea Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 189 Singapore Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 190 Singapore Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 191 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 192 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 193 Singapore Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 194 Singapore Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 195 Malaysia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 196 Malaysia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 197 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 198 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 199 Malaysia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 200 Malaysia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 201 Rest of Asia Pacific Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 202 Rest of Asia Pacific Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 203 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 204 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 205 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 206 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 207 LAMEA Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 208 LAMEA Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 209 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 210 LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 211 LAMEA Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
Table 212 LAMEA Hospital Pharmacy Market by Country, 2021-2027, USD Million
Table 213 LAMEA Retail Pharmacy Market by Country, 2017 - 2020, USD Million
Table 214 LAMEA Retail Pharmacy Market by Country, 2021-2027, USD Million
Table 215 LAMEA Online Pharmacy Market by Country, 2017 - 2020, USD Million
Table 216 LAMEA Online Pharmacy Market by Country, 2021-2027, USD Million
Table 217 LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 218 LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 219 LAMEA Idarucizumab Market by Country, 2017 - 2020, USD Million
Table 220 LAMEA Idarucizumab Market by Country, 2021-2027, USD Million
Table 221 LAMEA Andexanet Alfa Market by Country, 2017 - 2020, USD Million
Table 222 LAMEA Andexanet Alfa Market by Country, 2021-2027, USD Million
Table 223 LAMEA Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
Table 224 LAMEA Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
Table 225 LAMEA Phytonadione Market by Country, 2017 - 2020, USD Million
Table 226 LAMEA Phytonadione Market by Country, 2021-2027, USD Million
Table 227 LAMEA Other Product Type Market by Country, 2017 - 2020, USD Million
Table 228 LAMEA Other Product Type Market by Country, 2021-2027, USD Million
Table 229 LAMEA Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
Table 230 LAMEA Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
Table 231 Brazil Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 232 Brazil Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 233 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 234 Brazil Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 235 Brazil Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 236 Brazil Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 237 Argentina Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 238 Argentina Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 239 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 240 Argentina Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 241 Argentina Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 242 Argentina Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 243 UAE Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 244 UAE Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 245 UAE Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 246 UAE Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 247 UAE Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 248 UAE Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 249 Saudi Arabia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 250 Saudi Arabia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 251 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 252 Saudi Arabia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 253 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 254 Saudi Arabia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 255 South Africa Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 256 South Africa Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 257 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 258 South Africa Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 259 South Africa Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 260 South Africa Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 261 Nigeria Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 262 Nigeria Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 263 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 264 Nigeria Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 265 Nigeria Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 266 Nigeria Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 267 Rest of LAMEA Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
Table 268 Rest of LAMEA Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
Table 269 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
Table 270 Rest of LAMEA Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
Table 271 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
Table 272 Rest of LAMEA Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
Table 273 Key Information - Boehringer Ingelheim International GmbH
Table 274 key Information - CSL Limited
Table 275 key information - Bausch Health Companies, Inc.
Table 276 Key Information - Octapharma AG
Table 277 Key Information - Pfizer, Inc.
Table 278 key information - Fresenius SE & Co. KGaA
Table 279 key information - Alexion Pharmaceuticals, Inc.
Table 280 key information - Dr. Reddy’s Laboratories Ltd.
Table 281 key information - AMAG Pharmaceuticals, Inc.
Table 282 key information - Alps Pharmaceutical Ind. Co., Ltd.
List of Figures
Fig 1 Methodology for the research
Fig 2 Recent strategies and developments: AMAG Pharmaceuticals, Inc.
Companies Mentioned
- Boehringer Ingelheim International GmbH
- CSL Limited
- Bausch Health Companies, Inc.
- Octapharma AG
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- Dr. Reddy’s Laboratories Ltd.
- AMAG Pharmaceuticals, Inc. (Covis Pharma)
- Alps Pharmaceutical Ind. Co., Ltd.
Methodology
LOADING...
